Nanosphere Health Sciences Inc (NSHS.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
May 09, 16:00
Nanosphere Health Sciences Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2019 | -0.0676M |
September 30, 2019 | |
June 30, 2019 | 0.0056M |
March 31, 2019 | 0.3524M |
December 31, 2018 | -0.7186M |
September 30, 2018 | 0.4969M |
June 30, 2018 | 0.2598M |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 |
Date | Value |
---|---|
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 | |
June 30, 2009 | |
March 31, 2009 | |
December 31, 2008 | |
September 30, 2008 | |
June 30, 2008 | |
March 31, 2008 | |
December 31, 2007 | |
September 30, 2007 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.0676M
Minimum
Dec 2019
0.0056M
Maximum
Jun 2019
-0.031M
Average
-0.031M
Median
Revenue (Quarterly) Benchmarks
Biocure Technology Inc | -- |
Core One Labs Inc | 0.0937M |
Nova Mentis Life Science Corp | 0.0283M |
Lobe Sciences Ltd | 0.1362M |
Algernon Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -0.0557M |
Total Expenses (Quarterly) | 0.0707M |
EPS Diluted (Quarterly) | -0.0054 |
Enterprise Value | 0.2414M |
Earnings Yield | -237.7% |
Normalized Earnings Yield | -4033.10 |